NCT06558201View on ClinicalTrials.gov

Open Label Extension Study of NCT06221852

NAEnrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 28, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

December 30, 2027

Conditions
Bipolar I DisorderSchizoaffective DisorderPsychosis
Interventions
OTHER

Ketogenic diet

The ketogenic diet (KD) is a normo-caloric diet composed of high-fat, low carbohydrate, and adequate protein intake. The KD will consist of 3 meals a day plus snacks, targeting 75-80% fat, 13-18% protein, 7% carbohydrates.

Trial Locations (1)

02487

McLean Hospital, Belmont

All Listed Sponsors
collaborator

Baszucki Family Foundation

UNKNOWN

lead

Mclean Hospital

OTHER

NCT06558201 - Open Label Extension Study of NCT06221852 | Biotech Hunter | Biotech Hunter